Projects per year
A/Prof Bernard Champion is a Sydney-trained Endocrinologist. He started life at Macquarie University in Actuarial Studies, before returning to the more austere environment of the UNSW Medical Program & SVH Clinical School before undertaking his Physician Training in Endocrinology at RNS, POW, St George and Westmead Hospitals.
After 3-years in as an Academic VMO in Geelong he returned to Sydney in 2006 to the newly established Nepean Clinical School and was Head of Department, Endocrinology & Diabetes for Nepean Blue Mountains LHD for several years. He has held various state and national appointments including being Series Editor for Endocrinology Today, expert reviewer for several national and international journals, an FRACP Written Exam Committee member and Chair of the NSW/ACT Central Endocrine Advanced Training Panel. He holds qualifications in Medical Education and acted as Clinical Studies Coordinator for the Sydney Medical Program from 2014-2016.
Since 2017 he has been Associate Professor in Medicine at Macquarie University Faculty of Medicine & Health Sciences, Stage 1 Lead for the Macquarie University MD Program and Head of the MQ Health Discipline of Endocrinology, leading a 5-member Endocrinology team.
He runs inpatient and outpatient services at Macquarie University, Blacktown and Penrith. His clinical and research interests include pituitary, adrenal, and thyroid disease, along with metabolic diseases including diabetes and obesity.
In 2017 with the assistance of Neurosurgeon A/Prof Andrew Davison, he established the MQ Health Multidisciplinary Pituitary Service, catering for public and privately insured patient with pituitary disorders across NSW.
A rare event: pituitary apoplexy 6 weeks after gamma knife radiosurgery for a non-functioning pituitary macroadenomaSach, G., Wu, Y-F., Fuller, J., Davidson, A., Champion, B. & Preda, V. A., Apr 2021, In: Journal of the Endocrine Society. 5, Supplement 1, p. A568-A569 2 p.
Research output: Contribution to journal › Meeting abstract › peer-reviewOpen AccessFile1 Downloads (Pure)
A safety and pharmacodynamics study of temelimab, an antipathogenic human endogenous retrovirus type W envelope monoclonal antibody, in patients with type 1 diabetesCurtin, F., Champion, B., Davoren, P., Duke, S., Ekinci, E. I., Gilfillan, C., Morbey, C., Nathow, T., O'Moore-Sullivan, T., O'Neal, D., Roberts, A., Stranks, S., Stuckey, B., Vora, P., Malpass, S., Lloyd, D., Maëstracci-Beard, N., Buffet, B., Kornmann, G., Bernard, C. & 2 others, , 1 Jul 2020, In: Diabetes, Obesity and Metabolism. 22, 7, p. 1111-1121 11 p.
Research output: Contribution to journal › Article › peer-review
Champion, B., Shalaby, G. & Preda, V., 8 May 2020, In: Journal of the Endocrine Society. 4, Supplement 1, p. A1043-A1044 2 p., SAT-LB307.
Research output: Contribution to journal › Meeting abstract › peer-reviewOpen AccessFile11 Downloads (Pure)